Treatment sequence with either irinotecan/cetuximab followed by FOLFOX-4 or the reverse strategy in metastatic colorectal cancer patients progressing after first-line FOLFIRI/bevacizumab: An Italian Group for the Study of Gastrointestinal Cancer phase III, randomised trial comparing two sequences of therapy in colorectal metastatic patients
Titel:
Treatment sequence with either irinotecan/cetuximab followed by FOLFOX-4 or the reverse strategy in metastatic colorectal cancer patients progressing after first-line FOLFIRI/bevacizumab: An Italian Group for the Study of Gastrointestinal Cancer phase III, randomised trial comparing two sequences of therapy in colorectal metastatic patients
Auteur:
Cascinu, Stefano Rosati, Gerardo Nasti, Guglielmo Lonardi, Sara Zaniboni, Alberto Marchetti, Paolo Leone, Francesco Bilancia, Domenico Iaffaioli, Rosario Vincenzo Zagonel, Vittorina Giordano, Monica Corsi, Domenico C. Ferraú, Francesco Labianca, Roberto Ronzoni, Monica Scartozzi, Mario Galli, Francesca